Clinical Pathways Search Results

The penicillin drug allergy pathway is meant to guide providers in assessing whether patients with a reported or labeled penicillin drug allergy should avoid penicillin, remove the allergy label, or refer to an allergist for skin testing or oral drug challenge.

This pathway guides the ED and inpatient care for patients of any age with Genetically confirmed, Primary (Definite) Mitochondrial Disease or Suspected Mitochondrial Disease.

The croup pathway highlights the care necessary in treating children with croup in the emergency department and inpatient settings.

Emergency Department pathway for infant presenting with a brief, resolved, concerning event.

Multisystem Inflammatory Syndrome (MIS-C), ED, ICU and Inpatient

The ED Coronavirus Pathway provides guidance for the evaluation and care of patients with laboratory-confirmed 2019-nCoV or who is under investigation for 2019-nCoV while that patient was ill.

Treatment of patients with active COVID-19 disease with guidance on severity of illness, recommendations for antivirals, steroids, immunomodulators, and convalescent plasma administration.

The emergent care bronchiolitis pathway highlights the care necessary in treating a child with bronchiolitis in the emergency department.

The pneumonia clinical pathway aids clinicians in determining the appropriate steps to be taken when evaluating and treating a child with community-acquired pneumonia.

The asthma pathway provides step-by-step guidance for evaluation and treatment of pediatric patients seen in the emergency department for asthma.